The results of the study demonstrated that in cisplatin-resistant ovarian cancer cells, cisplatin activates the nuclear and mitochondrial transcription systems by upregulating PGC1α expression, which mediates the expression of mitochondrial proteins encoded by both nuclear DNA and mitochondrial DNA. The gene discussed is PPARGC1A; the disease is ovarian cancer.